In a landmark achievement for Nigerian healthcare, two prominent Nigerian medical researchers, Professor Mohammed Manga and Dr. Qudus Olajide Lawal, have been appointed to the board of the International Papillomavirus Society (IPVS), the world’s foremost authority on Human Papillomavirus (HPV)-related diseases.
The appointments mark a historic first for Nigeria, signaling international recognition of the country’s rapid strides in combating cervical cancer and other HPV-associated illnesses.
Under the new board structure, Prof. Manga will serve as a Senior Affiliate Board Member, while Dr Lawal joins as a non-voting ex officio member in his capacity as Chair of the society’s Early Career Researcher (ECR) Committee.
Profiles in Leadership
Prof. Mohammed Manga is a Professor of Medical Microbiology, former Provost of the College of Medical Sciences at Gombe State University, and an honorary consultant at the Federal Teaching Hospital, Gombe. Within the global body, he serves as the IPVS Nigeria Chapter President and Country Ambassador, sits on the IPVS Membership Committee and spearheaded the Papillomavirus Society of Gombe Nigeria (PSGN).
Dr. Qudus Olajide Lawal is a Consultant Obstetrician and Gynaecologist (Oncology) at the Irrua Specialist Teaching Hospital, Edo State, and serves on Nigeria’s National Task Force for Cervical Cancer Elimination (NTFCCE). He also serves as the ED of End Cervical Cancer Initiative, a NGO working to ensure Nigeria achieves its elimination targets.
Currently the IPVS Nigeria Program Coordinator, he assumes the role of Chair of the IPVS Early Career Researcher (ECR) Committee following four years on the committee, during which he served as Vice Chair and co-chaired both the 2024 oral abstract sessions and the 2026 ECR program committee.
A Call to Action and Upcoming Abuja Summit
Reacting to their appointments, both experts described the milestone not merely as a personal accolade, but as a critical call to action. They pledged to leverage their new positions and global networks to bolster federal and state government efforts toward eliminating cervical cancer and other HPV-related diseases across Nigeria.
Building on this momentum, the IPVS Nigeria Chapter will host its third International HPV Awareness Day in Abuja in March 2027. The landmark event will convene leading medical experts, journalists, policymakers, and stakeholders to strategize on scaling up HPV elimination activities nationwide. These developments reflect growing global acclaim for Nigeria’s aggressive public health policies against HPV.
Since introducing the HPV vaccine into its routine immunization schedule in 2024, Nigeria has achieved unprecedented vaccine coverage within its first two years, alongside the establishment of the NTFCCE as a dedicated agency to accelerate cervical cancer elimination.



